Vincerx Pharma, Inc.
VINC · NASDAQ
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | $2,771 | $27,532 | $79,733 | $84,577 |
| - Cash | $4,437 | $4,987 | $2,942 | $7,923 |
| + Debt | $0 | $0 | $1,639 | $1,933 |
| Enterprise Value | -$1,666 | $22,545 | $78,430 | $78,587 |
| Revenue | $0 | $1,068 | $0 | $0 |
| % Growth | -100% | – | – | – |
| Gross Profit | $0 | $534 | $0 | -$270 |
| % Margin | – | 50% | – | – |
| EBITDA | -$3,334 | -$8,545 | -$7,518 | -$7,096 |
| % Margin | – | -800.1% | – | – |
| Net Income | -$5,000 | -$7,994 | -$7,843 | -$1,808 |
| % Margin | – | -748.5% | – | – |
| EPS Diluted | -0.96 | 4.22 | -1.41 | -0.32 |
| % Growth | -122.7% | 399.3% | -340.6% | – |
| Operating Cash Flow | -$4,454 | -$6,181 | -$6,379 | -$5,828 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$4,454 | -$6,181 | -$6,379 | -$5,828 |